Literature DB >> 27312539

Peripheral choroidal neovascular membrane in a case of peripheral exudative hemorrhagic chorioretinopathy managed with combination therapy.

Brijesh Takkar1, Sangeeta Roy2, Preet Kanwar Singh Sodhi3, Shorya Azad2, Gurkirat Singh Bajwa3.   

Abstract

To report a case of peripheral exudative hemorrhagic chorioretinopathy (PEHCR) associated with extramacular choroidal neovascular membrane (CNVM). A 65-year-old female with BCVA of 3/60 in the RE was diagnosed to have PEHCR with peripheral CNVM. She had subretinal fluid in the macular region. The patient was treated successfully with a single dose of intravitreal bevacizumab followed by laser photocoagulation of the CNVM. BCVA was 6/24 after 3 months and subretinal fluid had resolved. PEHCR may be associated with extramacular CNVM and hence may cause visual loss. Such extramacular CNVMs respond well to combination therapy which offers a permanent cure.

Entities:  

Keywords:  Choroidal neovascular membrane; Peripheral exudative hemorrhagic chorioretinopathy; Photocoagulation; Retinal degeneration

Mesh:

Substances:

Year:  2016        PMID: 27312539     DOI: 10.1007/s10792-016-0277-5

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  7 in total

1.  Predictors of visual outcome and choroidal neovascular membrane formation after traumatic choroidal rupture.

Authors:  Christine Shortsleeve Ament; David N Zacks; Anne Marie Lane; Magdalena Krzystolik; Donald J D'Amico; Shizuo Mukai; Lucy H Young; John Loewenstein; Jorge Arroyo; Joan W Miller
Journal:  Arch Ophthalmol       Date:  2006-07

2.  Anti-VEGF therapy in symptomatic peripheral exudative hemorrhagic chorioretinopathy (PEHCR) involving the macula.

Authors:  Ira Seibel; Annette Hager; Tobias Duncker; Aline I Riechardt; Daniela Nürnberg; Julian P Klein; Matus Rehak; Antonia M Joussen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-07-07       Impact factor: 3.117

3.  Peripheral exudative hemorrhagic chorioretinopathy.

Authors:  W H Annesley
Journal:  Trans Am Ophthalmol Soc       Date:  1980

4.  Peripheral exudative hemorrhagic chorioretinopathy simulating choroidal melanoma in 173 eyes.

Authors:  Carol L Shields; Pedro F Salazar; Arman Mashayekhi; Jerry A Shields
Journal:  Ophthalmology       Date:  2009-01-20       Impact factor: 12.079

5.  Intermediate uveitis complicated by choroidal granuloma following subretinal neovascular membrane: case reports.

Authors:  Carlos Alexandre de Amorim Garcia; Paulo de Souza Segundo; Carlos Alexandre de Amorim Garcia Filho; Ana Cláudia Medeiros de Amorim Garcia
Journal:  Arq Bras Oftalmol       Date:  2008 Nov-Dec       Impact factor: 0.872

6.  Management of peripheral polypoidal choroidal vasculopathy with intravitreal bevacizumab and indocyanine green angiography-guided laser photocoagulation.

Authors:  Pukhraj Rishi; Atheeswar Das; Pallavi Sarate; Ekta Rishi
Journal:  Indian J Ophthalmol       Date:  2012 Jan-Feb       Impact factor: 1.848

7.  Peripheral exudative hemorrhagic chorioretinopathy: a variant of polypoidal choroidal vasculopathy?

Authors:  Arman Mashayekhi; Carol L Shields; Jerry A Shields
Journal:  J Ophthalmic Vis Res       Date:  2013-07
  7 in total
  1 in total

1.  Updated Systematic Review and Clinical Spectrum of Peripheral Exudative Hemorrhagic Chorioretinopathy.

Authors:  Abdulrahman H Badawi; Valmore A Semidey; Moustafa Magliyah; Hassan Al-Dhibi
Journal:  Middle East Afr J Ophthalmol       Date:  2020-04-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.